Abstract |
Regulated in development and DNA damage response 1 (REDD1) expression is upregulated in response to metabolic imbalance and obesity. However, its role in obesity-associated complications is unclear. Here, we demonstrate that the REDD1-NF-κB axis is crucial for metabolic inflammation and dysregulation. Mice lacking Redd1 in the whole body or adipocytes exhibited restrained diet-induced obesity, inflammation, insulin resistance, and hepatic steatosis. Myeloid Redd1-deficient mice showed similar results, without restrained obesity and hepatic steatosis. Redd1-deficient adipose-derived stem cells lost their potential to differentiate into adipocytes; however, REDD1 overexpression stimulated preadipocyte differentiation and proinflammatory cytokine expression through atypical IKK-independent NF-κB activation by sequestering IκBα from the NF-κB/IκBα complex. REDD1 with mutated Lys219/220Ala, key amino acid residues for IκBα binding, could not stimulate NF-κB activation, adipogenesis, and inflammation in vitro and prevented obesity-related phenotypes in knock-in mice. The REDD1-atypical NF-κB activation axis is a therapeutic target for obesity, meta- inflammation, and metabolic complications.
|
Authors | Dong-Keon Lee, Taesam Kim, Junyoung Byeon, Minsik Park, Suji Kim, Joohwan Kim, Seunghwan Choi, Gihwan Lee, Chanin Park, Keun Woo Lee, Yong Jung Kwon, Jeong-Hyung Lee, Young-Guen Kwon, Young-Myeong Kim |
Journal | Nature communications
(Nat Commun)
Vol. 13
Issue 1
Pg. 6303
(10 22 2022)
ISSN: 2041-1723 [Electronic] England |
PMID | 36272977
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- NF-kappa B
- NF-KappaB Inhibitor alpha
- Cytokines
- Amino Acids
|
Topics |
- Mice
- Animals
- NF-kappa B
(metabolism)
- NF-KappaB Inhibitor alpha
(genetics)
- Obesity
(complications, genetics, metabolism)
- Inflammation
(metabolism)
- Fatty Liver
(metabolism)
- Cytokines
- Amino Acids
|